Trial intelligence / Profile preview

Tramadol immediate-release plus micronized magnesium lactate for chronic osteoarthritis pain

2014-004718-27Phase 3Completed

Sponsor
Medical University of Warsaw
Start
Dec 2016
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 3, randomised, single-blind trial in osteoarthritis (OA) comparing Tramadol immediate-release + micronized magnesium lactate with Active control tramadol (2 arms). Primary endpoint: Change in pain intensity from baseline to end of treatment. Started Dec 2016; status: completed.

02

Drugs

tramadolmagnesium
03

Conditions

osteoarthritis (OA)

Beyond the preview

Go deeper on 2014-004718-27.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2014-004718-27.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call